Immunotherapy Drugs Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Immunotherapy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immunotherapy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immunotherapy Drugs Overall Market Size
2.1 Global Immunotherapy Drugs Market Size: 2021 VS 2027
2.2 Global Immunotherapy Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immunotherapy Drugs Players in Global Market
3.2 Top Global Immunotherapy Drugs Companies Ranked by Revenue
3.3 Global Immunotherapy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Immunotherapy Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Immunotherapy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immunotherapy Drugs Players in Global Market
3.6.1 List of Global Tier 1 Immunotherapy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Immunotherapy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immunotherapy Drugs Market Size Markets, 2021 & 2027
4.1.2 Monoclonal Antibodies
4.1.3 Adult Vaccines
4.1.4 Checkpoint Inhibitors
4.1.5 Interferons Alpha & Beta
4.1.6 Interleukins
4.1.7 Others
4.2 By Type - Global Immunotherapy Drugs Revenue & Forecasts
4.2.1 By Type - Global Immunotherapy Drugs Revenue, 2016-2021
4.2.2 By Type - Global Immunotherapy Drugs Revenue, 2022-2027
4.2.3 By Type - Global Immunotherapy Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immunotherapy Drugs Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Autoimmune & Inflammatory Diseases
5.1.4 Infectious Diseases
5.1.5 Others
5.2 By Application - Global Immunotherapy Drugs Revenue & Forecasts
5.2.1 By Application - Global Immunotherapy Drugs Revenue, 2016-2021
5.2.2 By Application - Global Immunotherapy Drugs Revenue, 2022-2027
5.2.3 By Application - Global Immunotherapy Drugs Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Immunotherapy Drugs Market Size, 2021 & 2027
6.2 By Region - Global Immunotherapy Drugs Revenue & Forecasts
6.2.1 By Region - Global Immunotherapy Drugs Revenue, 2016-2021
6.2.2 By Region - Global Immunotherapy Drugs Revenue, 2022-2027
6.2.3 By Region - Global Immunotherapy Drugs Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Immunotherapy Drugs Revenue, 2016-2027
6.3.2 US Immunotherapy Drugs Market Size, 2016-2027
6.3.3 Canada Immunotherapy Drugs Market Size, 2016-2027
6.3.4 Mexico Immunotherapy Drugs Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Immunotherapy Drugs Revenue, 2016-2027
6.4.2 Germany Immunotherapy Drugs Market Size, 2016-2027
6.4.3 France Immunotherapy Drugs Market Size, 2016-2027
6.4.4 U.K. Immunotherapy Drugs Market Size, 2016-2027
6.4.5 Italy Immunotherapy Drugs Market Size, 2016-2027
6.4.6 Russia Immunotherapy Drugs Market Size, 2016-2027
6.4.7 Nordic Countries Immunotherapy Drugs Market Size, 2016-2027
6.4.8 Benelux Immunotherapy Drugs Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Immunotherapy Drugs Revenue, 2016-2027
6.5.2 China Immunotherapy Drugs Market Size, 2016-2027
6.5.3 Japan Immunotherapy Drugs Market Size, 2016-2027
6.5.4 South Korea Immunotherapy Drugs Market Size, 2016-2027
6.5.5 Southeast Asia Immunotherapy Drugs Market Size, 2016-2027
6.5.6 India Immunotherapy Drugs Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Immunotherapy Drugs Revenue, 2016-2027
6.6.2 Brazil Immunotherapy Drugs Market Size, 2016-2027
6.6.3 Argentina Immunotherapy Drugs Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immunotherapy Drugs Revenue, 2016-2027
6.7.2 Turkey Immunotherapy Drugs Market Size, 2016-2027
6.7.3 Israel Immunotherapy Drugs Market Size, 2016-2027
6.7.4 Saudi Arabia Immunotherapy Drugs Market Size, 2016-2027
6.7.5 UAE Immunotherapy Drugs Market Size, 2016-2027
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Immunotherapy Drugs Major Product Offerings
7.1.4 Roche Immunotherapy Drugs Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Immunotherapy Drugs Major Product Offerings
7.2.4 Merck Immunotherapy Drugs Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Immunotherapy Drugs Major Product Offerings
7.3.4 Novartis Immunotherapy Drugs Revenue in Global (2016-2021)
7.3.5 Novartis Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Immunotherapy Drugs Major Product Offerings
7.4.4 Johnson & Johnson Immunotherapy Drugs Revenue in Global (2016-2021)
7.4.5 Johnson & Johnson Key News
7.5 Glaxosmithkline
7.5.1 Glaxosmithkline Corporate Summary
7.5.2 Glaxosmithkline Business Overview
7.5.3 Glaxosmithkline Immunotherapy Drugs Major Product Offerings
7.5.4 Glaxosmithkline Immunotherapy Drugs Revenue in Global (2016-2021)
7.5.5 Glaxosmithkline Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Immunotherapy Drugs Major Product Offerings
7.6.4 Amgen Immunotherapy Drugs Revenue in Global (2016-2021)
7.6.5 Amgen Key News
7.7 Abbvie
7.7.1 Abbvie Corporate Summary
7.7.2 Abbvie Business Overview
7.7.3 Abbvie Immunotherapy Drugs Major Product Offerings
7.4.4 Abbvie Immunotherapy Drugs Revenue in Global (2016-2021)
7.7.5 Abbvie Key News
7.8 Astrazeneca
7.8.1 Astrazeneca Corporate Summary
7.8.2 Astrazeneca Business Overview
7.8.3 Astrazeneca Immunotherapy Drugs Major Product Offerings
7.8.4 Astrazeneca Immunotherapy Drugs Revenue in Global (2016-2021)
7.8.5 Astrazeneca Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Immunotherapy Drugs Major Product Offerings
7.9.4 Bristol-Myers Squibb Immunotherapy Drugs Revenue in Global (2016-2021)
7.9.5 Bristol-Myers Squibb Key News
7.10 ELI Lilly
7.10.1 ELI Lilly Corporate Summary
7.10.2 ELI Lilly Business Overview
7.10.3 ELI Lilly Immunotherapy Drugs Major Product Offerings
7.10.4 ELI Lilly Immunotherapy Drugs Revenue in Global (2016-2021)
7.10.5 ELI Lilly Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Immunotherapy Drugs Market Opportunities & Trends in Global Market
Table 2. Immunotherapy Drugs Market Drivers in Global Market
Table 3. Immunotherapy Drugs Market Restraints in Global Market
Table 4. Key Players of Immunotherapy Drugs in Global Market
Table 5. Top Immunotherapy Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Immunotherapy Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Immunotherapy Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Immunotherapy Drugs Product Type
Table 9. List of Global Tier 1 Immunotherapy Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immunotherapy Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Immunotherapy Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Immunotherapy Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Immunotherapy Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Immunotherapy Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Immunotherapy Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Immunotherapy Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Immunotherapy Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Immunotherapy Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Immunotherapy Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Immunotherapy Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Immunotherapy Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Immunotherapy Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Immunotherapy Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Immunotherapy Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Immunotherapy Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Immunotherapy Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Immunotherapy Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Immunotherapy Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Immunotherapy Drugs Revenue, (US$, Mn), 2022-2027
Table 30. Roche Corporate Summary
Table 31. Roche Immunotherapy Drugs Product Offerings
Table 32. Roche Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Merck Corporate Summary
Table 34. Merck Immunotherapy Drugs Product Offerings
Table 35. Merck Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Novartis Corporate Summary
Table 37. Novartis Immunotherapy Drugs Product Offerings
Table 38. Novartis Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Immunotherapy Drugs Product Offerings
Table 41. Johnson & Johnson Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Glaxosmithkline Corporate Summary
Table 43. Glaxosmithkline Immunotherapy Drugs Product Offerings
Table 44. Glaxosmithkline Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Amgen Corporate Summary
Table 46. Amgen Immunotherapy Drugs Product Offerings
Table 47. Amgen Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 48. Abbvie Corporate Summary
Table 49. Abbvie Immunotherapy Drugs Product Offerings
Table 50. Abbvie Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Astrazeneca Corporate Summary
Table 52. Astrazeneca Immunotherapy Drugs Product Offerings
Table 53. Astrazeneca Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Immunotherapy Drugs Product Offerings
Table 56. Bristol-Myers Squibb Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 57. ELI Lilly Corporate Summary
Table 58. ELI Lilly Immunotherapy Drugs Product Offerings
Table 59. ELI Lilly Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Immunotherapy Drugs Segment by Type
Figure 2. Immunotherapy Drugs Segment by Application
Figure 3. Global Immunotherapy Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Immunotherapy Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Immunotherapy Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immunotherapy Drugs Revenue in 2020
Figure 8. By Type - Global Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 12. US Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 24. China Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. Roche Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Merck Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Novartis Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Johnson & Johnson Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Glaxosmithkline Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Amgen Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Abbvie Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Astrazeneca Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Bristol-Myers Squibb Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. ELI Lilly Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly